Stark Charles William 4
4 · Emmaus Life Sciences, Inc. · Filed Jan 17, 2023
Insider Transaction Report
Form 4
Stark Charles William
SVP, Clinical Development
Transactions
- Award
Options
2023-01-12$4.50/sh+100,000$450,000→ 100,000 totalExercise: $4.50Exp: 2033-01-11→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The options vest as to one-third of the option shares on the 12-month anniversary of the grant date and as to the remaining two-thirds of the option shares in 24 equal monthly installments as of the end of each month after such anniversary.